Squarepoint’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $367K | Sell |
|
|||||
|
2024
Q4 | $1.8M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $204K | Sell |
|
|||||
|
2022
Q3 | $1.02M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $885K | Buy |
|
|||||
|
2021
Q4 | $202K | Sell |
|
|||||
|
2021
Q3 | $610K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $700K | Buy |
|
|||||
|
2020
Q4 | $360K | Sell |
|
|||||
|
2020
Q3 | $945K | Buy |
|
|||||
|
2020
Q2 | $1.06M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $877K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $920K | Sell |
|
|||||
|
2019
Q1 | $1.72M | Sell |
|
|||||
|
2018
Q4 | $3.23M | Buy |
|
|||||
|
2018
Q3 | $665K | Buy |
|
|||||
|
2018
Q2 | $312K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $354K | Sell |
|
|||||
|
2017
Q2 | $986K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $350K | Sell |
|
|||||
|
2015
Q3 | $314K | Sell |
|
|||||
|
2015
Q2 | $656K | Buy |
|